Information  X 
Enter a valid email address

Sirius Minerals plc (SXX)

  Print      Mail a friend       Annual reports

Wednesday 18 September, 2019

Sirius Minerals plc

Director/PDMR Shareholding

RNS Number : 8413M
Sirius Minerals plc
18 September 2019
 

 

 

18 September 2019

 

Sirius Minerals Plc

Director Dealing

Sirius Minerals Plc (LSE: SXX, OTCQX: SRUXY) ("Sirius" or the "Company") was notified on 18 September 2019 that C&J Fraser Investments Pty Limited as trustee for The Fraser Family Trust, of which Christopher Fraser, Managing Director, is a beneficiary, purchased 250,000 of the Company's 0.25p ordinary shares at a price of 4.0088p each.  Following this transaction Mr Fraser has direct and indirect beneficial interests in 123,997,368 shares representing 1.77% of the Company's issued share capital.

As at the date of this announcement, the Company's issued share capital consists of 7,006,279,248 ordinary shares with voting rights.  This figure may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change of interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

This notification is intended to satisfy the Company's obligations under Disclosure and Transparency Rule 3.1.4R.

Further information

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transactions as described at the beginning of this announcement.

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Christopher Fraser

2

Reason for the notification

 

a)

Position/status

 

Managing Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Sirius Minerals plc

b)

LEI

 

2138004ATVA9GVUAGA82

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 0.25p

 

 

 

GB00B0DG3H29

b)

Nature of the transaction

 

Purchase of ordinary shares by C&J Fraser Investments Pty Limited as trustee for The Fraser Family Trust, of which Christopher Fraser is a beneficiary

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

4.0088p

250,000

d)

Aggregated information

 

-    Aggregated volume

 

-    Price

 

 

 

250,000

 

4.0088p

e)

Date of the transaction

 

18 September 2019

f)

Place of the transaction

 

London Stock Exchange

 

For further information, please contact:

Sirius Minerals Plc

Investor Relations

Jennifer Wyllie, Tristan Pottas

Email: [email protected]

Tel: +44 845 524 0247

Media enquiries

Edelman

Alex Simmons, Ed Brown

Email: [email protected]

Tel: +44 7970 174 353

Tel: +44 7540 412 298

 

About Sirius Minerals Plc

Sirius Minerals Plc is focused on bringing large scale volumes of POLY4 to the global agriculture industry.  POLY4 is the Company's trademarked name for its unique multi-nutrient fertilizer to be produced from the world's largest and highest grade polyhalite deposit located in North Yorkshire, United Kingdom, which can be used to increase balanced fertilization around the world.  Sirius Minerals' shares are traded on the Premium List of the London Stock Exchange.  Its shares are also traded in the United States on the OTCQX through a sponsored ADR facility.  Further information on the Company can be found at: www.siriusminerals.com.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHXVLFFKKFFBBQ

a d v e r t i s e m e n t